← Product Code [GGT](/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/GGT) · K893393

# EPO-TRAC BY RADIOIMMUNOASSAY (RIA) (K893393)

_Incstar Corp. · GGT · Nov 21, 1989 · Hematology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-h%E2%80%94hematology-kits-and-packages/GGT/K893393

## Device Facts

- **Applicant:** Incstar Corp.
- **Product Code:** [GGT](/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/GGT.md)
- **Decision Date:** Nov 21, 1989
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 864.7250
- **Device Class:** Class 2
- **Review Panel:** Hematology

## Regulatory Identification

A erythropoietin assay is a device that measures the concentration of erythropoietin (an enzyme that regulates the production of red blood cells) in serum or urine. This assay provides diagnostic information for the evaluation of erythrocytosis (increased total red cell mass) and anemia.

## Special Controls

*Classification.* Class II. The special control for this device is FDA's “Document for Special Controls for Erythropoietin Assay Premarket Notification (510(k)s).”

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-h%E2%80%94hematology-kits-and-packages/GGT/K893393](https://fda.innolitics.com/submissions/CH/subpart-h%E2%80%94hematology-kits-and-packages/GGT/K893393)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com